The agency is looking for way more than just a new commissioner.
Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Aïda Amer/Axios
Finding a new commissioner is only the beginning of what the Trump administration needs to do to rebuild the Food and Drug Administration — and none of it is easy.
Why it matters: More than a year of upheaval has left the agency's leadership decimated and its reputation for predictable, evidence-based decisions damaged.
Who Will Be FDA's Next Commissioner?
At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path
Why FDA Leadership Changes Matter For Every American
FDA shuffles top drug, biologics leaders in latest shakeup
Biopharma industry endorses Pazdur for FDA commissioner role - Pharmaceutical Technology
Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development
Trump's FDA head faces calls to meet the moment on abortion pill regulation
FDA drug center head fired after commissioner's exit, replaced by Davis
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up
